Viridian files application with US FDA to begin trial of VRDN-002 for eye disease
05 January 2022 - 1:25AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Apr 2024 to May 2024
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From May 2023 to May 2024